This CITF-funded study, led by Dr. Sasha Bernatsky from the Research Institute of the McGill University Health Centre and published in the Journal of Rheumatology, found that the proportion of people with autoimmune diseases who had received two vaccine doses was higher (83.8-88.2%) than in the general population (77.9%).